NCT02727816

Brief Summary

The aim of this non-dispensing study is to evaluate the clinical performance of different hydrogel contact lens designs.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
35

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2016

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 30, 2016

Completed
2 days until next milestone

Study Start

First participant enrolled

April 1, 2016

Completed
4 days until next milestone

First Posted

Study publicly available on registry

April 5, 2016

Completed
26 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2016

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2016

Completed
1.5 years until next milestone

Results Posted

Study results publicly available

February 6, 2018

Completed
Last Updated

February 6, 2018

Status Verified

July 1, 2017

Enrollment Period

1 month

First QC Date

March 30, 2016

Results QC Date

March 28, 2017

Last Update Submit

July 20, 2017

Conditions

Outcome Measures

Primary Outcomes (20)

  • Centration - Pair One

    Centration for filcon IV I (Base Curve (BC) 8.6) / ocufilcon D (pair one) is assessed. (optimum, decentration acceptable, decentration unacceptable).

    Baseline and 1 hour

  • Centration - Pair Two

    Centration for filcon IV I (Base Curve (BC) 8.7) / ocufilcon D (pair two) is assessed. (optimum, decentration acceptable, decentration unacceptable).

    Baseline and 1 hour

  • Centration - Pair Three

    Centration for methafilcon A (Base Curve (BC) 8.6) / ocufilcon D (pair three) is assessed. (optimum, decentration acceptable, decentration unacceptable).

    Baseline and 1 hour

  • Centration - Pair Four

    Centration for methafilcon A (Base Curve (BC) 8.7) / somofilcon A (pair four) is assessed. (optimum, decentration acceptable, decentration unacceptable).

    Baseline and 1 hour

  • Post-blink Movement - Pair One

    Post-blink movement for filcon IV I (BC 8.6) / ocufilcon D (pair one) is assessed. (0-5 Likert scale, 0=Insufficient, unacceptable movement, 4=Excessive, unacceptable movement).

    Baseline

  • Post-blink Movement - Pair One

    Post-blink movement for filcon IV I (BC 8.6) / ocufilcon D (pair one) is assessed. (0-5 Likert scale, 0=Insufficient, unacceptable movement, 4=Excessive, unacceptable movement).

    1 hour

  • Post-blink Movement - Pair Two

    Post-blink movement for filcon IV I (BC 8.7) / ocufilcon D (pair two) is assessed. (0-5 Likert scale, 0=Insufficient, unacceptable movement, 4=Excessive, unacceptable movement).

    Baseline

  • Post-blink Movement - Pair Two

    Post-blink movement for filcon IV I (BC 8.7) / ocufilcon D (pair two) is assessed. (0-5 Likert scale, 0=Insufficient, unacceptable movement, 4=Excessive, unacceptable movement).

    1 hour

  • Post-blink Movement - Pair Three

    Post-blink movement for methafilcon A (BC 8.6) / ocufilcon D (pair three) is assessed. (0-5 Likert scale, 0=Insufficient, unacceptable movement, 4=Excessive, unacceptable movement).

    Baseline

  • Post-blink Movement - Pair Three

    Post-blink movement for methafilcon A (BC 8.6) / ocufilcon D (pair three) is assessed. (0-5 Likert scale, 0=Insufficient, unacceptable movement, 4=Excessive, unacceptable movement).

    1 hour

  • Post-blink Movement - Pair Four

    Post-blink movement for methafilcon A (BC 8.7) / somofilcon A (pair four) is assessed. (0-5 Likert scale, 0=Insufficient, unacceptable movement, 4=Excessive, unacceptable movement).

    Baseline

  • Post-blink Movement - Pair Four

    Post-blink movement for methafilcon A (BC 8.7) / somofilcon A (pair four) is assessed. (0-5 Likert scale, 0=Insufficient, unacceptable movement, 4=Excessive, unacceptable movement).

    1 hour

  • Lens Tightness - Pair One

    Lens tightness on push on test for filcon IV I (BC 8.6) / ocufilcon D (pair one) is assessed. (0% - 100%, 100%=No movement, 50%=Optimum 0%=Falls from cornea without lid support)

    Baseline and 1 hour

  • Lens Tightness - Pair Two

    Lens tightness on push on test for filcon IV I (BC 8.7) / ocufilcon D (pair two) is assessed. (0% - 100%, 100%=No movement, 50%=Optimum 0%=Falls from cornea without lid support)

    Baseline and 1 hour

  • Lens Tightness - Pair Three

    Lens tightness on push on test for methafilcon A (BC 8.6) / ocufilcon D (pair three) is assessed. (0% - 100%, 100%=No movement, 50%=Optimum 0%=Falls from cornea without lid support)

    Baseline and 1 hour

  • Lens Tightness - Pair Four

    Lens tightness on push on test for methafilcon A (BC 8.7) / somofilcon A (pair four) is assessed. (0% - 100%, 100%=No movement, 50%=Optimum 0%=Falls from cornea without lid support)

    Baseline and 1 hour

  • Overall Fit Preference - Pair One

    Investigator's lens fit acceptance / acceptability for filcon IV I (BC 8.6) / ocufilcon D (pair one) is assessed. Three choices: filcon IV I (BC 8.6), ocufilcon D, or no preference.

    Baseline and 1 hour

  • Overall Fit Acceptance - Pair Two

    Investigator's lens fit acceptance / acceptability for filcon IV I (BC 8.7) / ocufilcon D (pair two) is assessed. Three choices: filcon IV I (BC 8.7), ocufilcon D, or no preference.

    Baseline and 1 hour

  • Overall Fit Acceptance - Pair Three

    Investigator's lens fit acceptance / acceptability for methafilcon A (BC 8.6) / ocufilcon D (pair three) is assessed. Three choices: methafilcon A (BC 8.6), ocufilcon D, or no preference.

    Baseline and 1 hour

  • Overall Fit Acceptance - Pair Four

    Investigator's lens fit acceptance / acceptability for methafilcon A (BC 8.7) / somofilcon A (pair four) is assessed. Three choices: methafilcon A (BC 8.7), somofilcon A, or no preference.

    Baseline and 1 hour

Study Arms (4)

filcon IV I (BC 8.6) / ocufilcon D (pair one)

EXPERIMENTAL

Participants were randomized to a test and control lens for each pair in a contralateral design.

Device: filcon IV I (BC 8.6)Device: ocufilcon D

filcon IV I (BC 8.7) / ocufilcon D (pair two)

EXPERIMENTAL

Participants were randomized to a test and control lens for each pair in a contralateral design.

Device: filcon IV I (BC 8.7)Device: ocufilcon D

methafilcon A (BC 8.6) / ocufilcon D (pair three)

EXPERIMENTAL

Participants were randomized to a test and control lens for each pair in a contralateral design.

Device: ocufilcon DDevice: methafilcon A (BC 8.6)

methafilcon A (BC 8.7) / somofilcon A (pair four)

EXPERIMENTAL

Participants were randomized to a test and control lens for each pair in a contralateral design.

Device: methafilcon A (BC 8.7)Device: somofilcon A

Interventions

control lens

filcon IV I (BC 8.6) / ocufilcon D (pair one)

control lens

filcon IV I (BC 8.7) / ocufilcon D (pair two)

test lens

filcon IV I (BC 8.6) / ocufilcon D (pair one)filcon IV I (BC 8.7) / ocufilcon D (pair two)methafilcon A (BC 8.6) / ocufilcon D (pair three)

control lens

methafilcon A (BC 8.6) / ocufilcon D (pair three)

control lens

methafilcon A (BC 8.7) / somofilcon A (pair four)

test lens

methafilcon A (BC 8.7) / somofilcon A (pair four)

Eligibility Criteria

Age18 Years - 40 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Is between 18 and 40 years of age (inclusive).
  • Has had a self-reported visual exam in the last two years.
  • Is an adapted soft CL (Contact Lens) wearer.
  • Has a CL spherical prescription between - 1.00 and - 6.00 (inclusive)
  • Has a spectacle cylinder up to 0.75D (Diopters) in each eye.
  • Can achieve best corrected spectacle distance visual acuity of 20/25 (0.10 logMAR) or better in each eye.
  • Can achieve a distance visual acuity of 20/30 (0.18 logMAR) or better in each eye with the study contact lenses.
  • Has clear corneas and no active ocular disease.
  • Has read, understood and signed the information consent letter.
  • Patient contact lens refraction should fit within the available parameters of the study lenses.
  • Is willing to comply with the wear schedule.
  • Is willing to comply with the visit schedule.

You may not qualify if:

  • A person will be excluded from the study if he/she:
  • Has never worn contact lenses before.
  • Currently wears rigid gas permeable contact lenses.
  • Has a history of not achieving comfortable CL wear (5 days per week; \> 8 hours/day)
  • Has a CL prescription outside the range of - 1.00 to - 6.00D
  • Has a spectacle cylinder ≥1.00D of cylinder in either eye.
  • Has contact lens best corrected distance vision worse than 20/25 (0.10 logMAR) in either eye.
  • Presence of clinically significant (grade 2-4) anterior segment abnormalities.
  • Presence of ocular or systemic disease or need of medications which might interfere with contact lens wear.
  • Slit lamp findings that would contraindicate contact lens wear such as:
  • Pathological dry eye or associated findings
  • Pterygium, pinguecula, or corneal scars within the visual axis
  • Neovascularization \> 0.75 mm in from of the limbus
  • Giant papillary conjunctivitis (GPC) worse than grade 1
  • Anterior uveitis or iritis (past or present)
  • +8 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Optometry Clinic, National Autonomous University

Mexico City, Mexico

Location

MeSH Terms

Conditions

Myopia

Condition Hierarchy (Ancestors)

Refractive ErrorsEye Diseases

Results Point of Contact

Title
Senior Manager Global Medical Scientific Affairs
Organization
CooperVision Inc.

Publication Agreements

PI is Sponsor Employee
No
Restriction Type
OTHER
Restrictive Agreement
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 30, 2016

First Posted

April 5, 2016

Study Start

April 1, 2016

Primary Completion

May 1, 2016

Study Completion

August 1, 2016

Last Updated

February 6, 2018

Results First Posted

February 6, 2018

Record last verified: 2017-07

Data Sharing

IPD Sharing
Will not share

Locations